Press Releases

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

 

 
Advanced Search
  • Dec 29, 2008
    Perrigo Announces FDA Final Approval for Ibuprofen PM

    Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for...

  • Dec 4, 2008
    Perrigo Settles Desloratadine Patent Litigation

    The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that all Hatch-Waxman litigation relating to Desloratadine tablets (5 mg) has been settled with Perrigo taking a license under all...

  • Nov 19, 2008
    Perrigo Acknowledges Settlement of NASACORT® AQ Nasal Spray Patent Litigation

    Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today acknowledges the settlement of patent litigation brought by Sanofi-Aventis (NYSE: SNY) against Barr Laboratories, Inc. a subsidiary of Barr...

  • Nov 13, 2008
    Perrigo Acquires Unico Holdings

    Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has acquired Unico Holdings for approximately $49 million in cash. Based in Lake Worth, Florida, privately-held Unico is the...

  • Nov 6, 2008
    Perrigo Reports Record First Quarter Sales and Income
    * Fiscal first quarter revenue of $480 million represents an increase of $97 million, or 25 percent, from first quarter last year

    Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its fiscal year 2009 first quarter that ended September 27, 2008. Perrigo Company (in thousands, except per share amounts)...

Show 5102550100 per page